[go: up one dir, main page]

SE9703458D0 - Nicotine compositions and methods of formulation thereof - Google Patents

Nicotine compositions and methods of formulation thereof

Info

Publication number
SE9703458D0
SE9703458D0 SE9703458A SE9703458A SE9703458D0 SE 9703458 D0 SE9703458 D0 SE 9703458D0 SE 9703458 A SE9703458 A SE 9703458A SE 9703458 A SE9703458 A SE 9703458A SE 9703458 D0 SE9703458 D0 SE 9703458D0
Authority
SE
Sweden
Prior art keywords
offspring
precursors
liquid crystals
dispersions
nicotine
Prior art date
Application number
SE9703458A
Other languages
English (en)
Swedish (sv)
Inventor
Sven Boerje Andersson
Stefan Jonn
Tomas Landh
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE9703458A priority Critical patent/SE9703458D0/xx
Publication of SE9703458D0 publication Critical patent/SE9703458D0/xx
Priority to PT98945685T priority patent/PT1023069E/pt
Priority to PCT/SE1998/001632 priority patent/WO1999015171A1/en
Priority to CN98810645A priority patent/CN1123343C/zh
Priority to NZ50340898A priority patent/NZ503408A/xx
Priority to JP2000512540A priority patent/JP2001517624A/ja
Priority to AT98945685T priority patent/ATE253362T1/de
Priority to ES98945685T priority patent/ES2210817T3/es
Priority to EEP200000154A priority patent/EE200000154A/xx
Priority to HU0004802A priority patent/HUP0004802A3/hu
Priority to RU2000110632/14A priority patent/RU2201747C2/ru
Priority to EP98945685A priority patent/EP1023069B1/en
Priority to AU92872/98A priority patent/AU733619B2/en
Priority to MXPA00002955A priority patent/MXPA00002955A/es
Priority to KR1020007003204A priority patent/KR20010024305A/ko
Priority to BR9815395-1A priority patent/BR9815395A/pt
Priority to DK98945685T priority patent/DK1023069T3/da
Priority to DE69819548T priority patent/DE69819548T2/de
Priority to CA002304042A priority patent/CA2304042A1/en
Priority to ZA988794A priority patent/ZA988794B/xx
Priority to NO20001540A priority patent/NO20001540L/no
Priority to FI20000692A priority patent/FI20000692L/fi
Priority to US10/389,148 priority patent/US20030176467A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE9703458A 1997-09-25 1997-09-25 Nicotine compositions and methods of formulation thereof SE9703458D0 (sv)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE9703458A SE9703458D0 (sv) 1997-09-25 1997-09-25 Nicotine compositions and methods of formulation thereof
CA002304042A CA2304042A1 (en) 1997-09-25 1998-09-15 Nicotine compositions and methods of formulation thereof
RU2000110632/14A RU2201747C2 (ru) 1997-09-25 1998-09-15 Композиция, заменяющая табак (варианты), способ ее получения, способ лечения табакокурения, способ лечения болезни альцгеймера, болезни паркинсона или неспецифического язвенного колита
AU92872/98A AU733619B2 (en) 1997-09-25 1998-09-15 Nicotine compositions and methods of formulation thereof
CN98810645A CN1123343C (zh) 1997-09-25 1998-09-15 烟碱组合物及其制备方法
NZ50340898A NZ503408A (en) 1997-09-25 1998-09-15 Nicotine compositions containing a local analgesuc or polar lipids and anionic surfactants
JP2000512540A JP2001517624A (ja) 1997-09-25 1998-09-15 ニコチン組成物およびその製剤方法
AT98945685T ATE253362T1 (de) 1997-09-25 1998-09-15 Nicotin enthaltende zusammensetzungen und verfahren zur ihrer formulierung
ES98945685T ES2210817T3 (es) 1997-09-25 1998-09-15 Composiciones de nicotina y metodos de formulacion de las mismas.
EEP200000154A EE200000154A (et) 1997-09-25 1998-09-15 Nikotiini sisaldav kompositsioon ja selle valmistamismeetod
HU0004802A HUP0004802A3 (en) 1997-09-25 1998-09-15 Nicotine compositions and methods of formulation thereof
PT98945685T PT1023069E (pt) 1997-09-25 1998-09-15 Composicoes de nicotina e seus processos de formulacao
EP98945685A EP1023069B1 (en) 1997-09-25 1998-09-15 Nicotine compositions and methods of formulation thereof
PCT/SE1998/001632 WO1999015171A1 (en) 1997-09-25 1998-09-15 Nicotine compositions and methods of formulation thereof
MXPA00002955A MXPA00002955A (es) 1997-09-25 1998-09-15 Composiciones de nicotina y metodos de formulacion de las mismas.
KR1020007003204A KR20010024305A (ko) 1997-09-25 1998-09-15 니코틴 조성물 및 이의 제형화 방법
BR9815395-1A BR9815395A (pt) 1997-09-25 1998-09-15 Composições à base de nicotina e método de formulção das mesmas
DK98945685T DK1023069T3 (da) 1997-09-25 1998-09-15 Nikotinsammensætninger og fremgangsmåder til fremstilling deraf
DE69819548T DE69819548T2 (de) 1997-09-25 1998-09-15 Nicotin enthaltende zusammensetzungen und verfahren zur ihrer formulierung
ZA988794A ZA988794B (en) 1997-09-25 1998-09-25 Nicotine compositions and methods of formulation thereof
NO20001540A NO20001540L (no) 1997-09-25 2000-03-24 Nikotinblandinger, samt fremgangsmÕter ved fremstilling derav
FI20000692A FI20000692L (fi) 1997-09-25 2000-03-24 Nikotiinikoostumuksia ja menetelmiä niiden koostamiseksi
US10/389,148 US20030176467A1 (en) 1997-09-25 2003-03-14 Nicotine compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703458A SE9703458D0 (sv) 1997-09-25 1997-09-25 Nicotine compositions and methods of formulation thereof

Publications (1)

Publication Number Publication Date
SE9703458D0 true SE9703458D0 (sv) 1997-09-25

Family

ID=20408364

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9703458A SE9703458D0 (sv) 1997-09-25 1997-09-25 Nicotine compositions and methods of formulation thereof

Country Status (22)

Country Link
EP (1) EP1023069B1 (fi)
JP (1) JP2001517624A (fi)
KR (1) KR20010024305A (fi)
CN (1) CN1123343C (fi)
AT (1) ATE253362T1 (fi)
AU (1) AU733619B2 (fi)
BR (1) BR9815395A (fi)
CA (1) CA2304042A1 (fi)
DE (1) DE69819548T2 (fi)
DK (1) DK1023069T3 (fi)
EE (1) EE200000154A (fi)
ES (1) ES2210817T3 (fi)
FI (1) FI20000692L (fi)
HU (1) HUP0004802A3 (fi)
MX (1) MXPA00002955A (fi)
NO (1) NO20001540L (fi)
NZ (1) NZ503408A (fi)
PT (1) PT1023069E (fi)
RU (1) RU2201747C2 (fi)
SE (1) SE9703458D0 (fi)
WO (1) WO1999015171A1 (fi)
ZA (1) ZA988794B (fi)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
US8256433B2 (en) 1999-07-16 2012-09-04 Aradigm Corporation Systems and methods for effecting cessation of tobacco use
US6799576B2 (en) 1999-07-16 2004-10-05 Aradigm Corporation System for effecting smoking cessation
AT409219B (de) * 1999-08-13 2002-06-25 Red Bull Gmbh Verwendung von nikotin zum herstellen von arzneimitteln
KR100381622B1 (ko) * 2000-08-30 2003-04-26 디디에스텍주식회사 자극성을 줄인 염기성 약물의 구강 투여 조성물
DE10057769A1 (de) * 2000-11-22 2002-05-23 Beiersdorf Ag Haarpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
AU2003209750A1 (en) * 2002-03-30 2003-10-13 Gunther Beisel Preparation containing fatty acid, used for reducing appetite, satiating, and/or reducing weight
US20040002520A1 (en) * 2002-07-01 2004-01-01 Soderlund Patrick L. Composition and method for cessation of Nicotine cravings
KR100443722B1 (ko) * 2002-09-26 2004-08-09 이용원 니코틴을 함유한 하드츄잉캔디 및 그의 제조방법
ATE359075T1 (de) 2002-12-20 2007-05-15 Niconovum Ab Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose
FR2851470B1 (fr) * 2003-02-20 2007-11-16 Besins Int Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse
US9498454B2 (en) 2003-02-24 2016-11-22 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US9358296B2 (en) 2003-02-24 2016-06-07 Pharmaceutical Productions Inc. Transmucosal drug delivery system
KR20120066688A (ko) 2003-02-24 2012-06-22 파마슈티칼 프로덕션스, 인크. 경점막 약물 전달 시스템
US10172810B2 (en) 2003-02-24 2019-01-08 Pharmaceutical Productions, Inc. Transmucosal ketamine delivery composition
US9254294B2 (en) 2003-02-24 2016-02-09 Pharmaceutical Productions Inc. Transmucosal hormone delivery system
RU2250057C2 (ru) * 2003-05-16 2005-04-20 Квасенков Олег Иванович Способ производства некурительного табачного изделия
RU2250051C2 (ru) * 2003-05-16 2005-04-20 Квасенков Олег Иванович Способ производства некурительного табачного изделия
RU2250052C2 (ru) * 2003-05-16 2005-04-20 Квасенков Олег Иванович Способ производства некурительного табачного изделия
RU2351315C2 (ru) * 2003-07-24 2009-04-10 Смитклайн Бичам Корпорейшн Пленки, растворяющиеся в полости рта
GB0322033D0 (en) * 2003-09-19 2003-10-22 Camurus Ab Composition
US8469036B2 (en) 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US7125954B2 (en) 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
US20080219935A1 (en) * 2005-07-08 2008-09-11 Sang-Hoon Kwak Phase Transitive Breath Care Products
AU2007224584A1 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
US20100247653A1 (en) * 2006-04-11 2010-09-30 Hans Lautenschlager Nanoparticles containing nicotine and/or cotinine, dispersions, and use thereof
US20080287507A1 (en) * 2007-05-16 2008-11-20 John Hedenstrom Nicotine containing toiletry waters
GB2469792A (en) * 2009-04-23 2010-11-03 Calvin John Ross Oil-based pharmaceutical formulation for sublingual delivery
GB2476471A (en) * 2009-12-22 2011-06-29 Norwich Pharma Technologies Ltd Cotinine formulation for the treatment of obesity
US8846725B2 (en) * 2011-01-24 2014-09-30 Quadex Pharmaceuticals, Llc Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
CN102552405B (zh) * 2012-03-21 2013-10-16 张伟 一种肛周术后麻醉镇痛的药物组合物的制备方法
CN103040741B (zh) * 2012-12-11 2014-11-05 中山大学 溶致液晶的前体混悬液及其制备方法
WO2014135630A1 (en) * 2013-03-07 2014-09-12 Danmarks Tekniske Universitet Nano-microdelivery systems for oromucosal delivery of an active ingredient
ES2999088T3 (en) * 2013-05-06 2025-02-24 Juul Labs Inc Nicotine salt formulations for aerosol devices and methods thereof
WO2015090337A1 (en) * 2013-12-20 2015-06-25 Fertin Pharma A/S Nicotine powder composition
CN105828819A (zh) * 2014-04-08 2016-08-03 桑萨（巴巴多斯）公司 烟碱制剂及其制备方法
GB201414919D0 (en) * 2014-08-21 2014-10-08 Corbitt Terence Simon Formulations for transmucosal delivery
CN108472251B (zh) * 2016-01-13 2022-02-01 株式会社 Lg 生活健康 口腔用制剂
CN108323791B (zh) * 2018-01-03 2021-02-12 云南中烟工业有限责任公司 一种尼古丁-氧化锌复合物、其制备方法及包含其的烟草制品
AU2019256805B2 (en) * 2018-04-16 2022-03-03 Poviva Corp. Compositions infused with nicotine compounds and methods of use thereof
CN109125251B (zh) * 2018-09-10 2021-08-13 武汉百纳礼康生物制药有限公司 一种包载蛋白类药物的温敏性液晶凝胶制剂及其制备方法
KR102186704B1 (ko) * 2019-02-18 2020-12-04 (주)아이엠디팜 서방성 지질 전구 제제 및 이를 포함하는 지질 용액 형태의 서방성 주사용 약학 조성물
LU101520B1 (en) * 2019-12-02 2021-06-07 Herrera Arturo Solis (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a homogeneous, viscous, semi-solid topical medication and topical medication
LU101511B1 (en) * 2019-12-02 2021-06-04 Herrera Arturo Solis (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a parenteral administration and a process for the preparation of an injectable substance
US12137723B2 (en) 2019-12-09 2024-11-12 Nicoventures Trading Limited Oral products with active ingredient combinations
NL2031332B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of psychoactive compounds
NL2031331B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of a short-acting psychedelic compound
EP4570082A1 (en) * 2023-12-15 2025-06-18 Contraf-Nicotex-Tobacco GmbH Oral product for delivery of nicotine comprising a nicotine salt of a fatty acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5371109A (en) * 1986-07-01 1994-12-06 Drilletten Ab Controlled release composition for a biologically active material dissolved or dispersed in an L2-phase
IL86170A (en) * 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
US4908213A (en) * 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
GB2230439A (en) * 1989-04-20 1990-10-24 Alec Stanley Walter Shaw Nicotine lozenges
AU2699892A (en) * 1991-10-04 1993-05-03 Gs Biochem Ab Particles, method of preparing said particles and uses thereof
CA2231273A1 (en) * 1995-10-12 1997-04-17 Lise Sylvest Nielsen A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface

Also Published As

Publication number Publication date
NZ503408A (en) 2004-12-24
ES2210817T3 (es) 2004-07-01
RU2201747C2 (ru) 2003-04-10
DE69819548T2 (de) 2004-08-12
ATE253362T1 (de) 2003-11-15
PT1023069E (pt) 2004-02-27
NO20001540D0 (no) 2000-03-24
CN1123343C (zh) 2003-10-08
AU733619B2 (en) 2001-05-17
BR9815395A (pt) 2000-11-14
ZA988794B (en) 1999-04-01
HUP0004802A3 (en) 2001-12-28
CA2304042A1 (en) 1999-04-01
HUP0004802A2 (hu) 2001-05-28
KR20010024305A (ko) 2001-03-26
AU9287298A (en) 1999-04-12
DK1023069T3 (da) 2004-03-08
FI20000692A7 (fi) 2000-03-24
DE69819548D1 (de) 2003-12-11
JP2001517624A (ja) 2001-10-09
CN1278174A (zh) 2000-12-27
EP1023069A1 (en) 2000-08-02
FI20000692L (fi) 2000-03-24
WO1999015171A1 (en) 1999-04-01
EE200000154A (et) 2001-02-15
MXPA00002955A (es) 2002-04-24
NO20001540L (no) 2000-05-25
EP1023069B1 (en) 2003-11-05

Similar Documents

Publication Publication Date Title
SE9703458D0 (sv) Nicotine compositions and methods of formulation thereof
ATE497745T1 (de) Zusammensetzungen mit verzögerter freisetzung mit progesteron-rezeptormodulatoren
EP1124551A4 (en) AEROSOL-DOSERS FOR DELTA 9 -TETRAHYDROCANNABINOL SOLUTION (DELTA 9 THC) AND THEIR METHOD OF USE
BR0110767A (pt) Derivados de piperidina farmaceuticamente ativos, em particular como moduladores da atividade de receptor de quimiocina
RU94040387A (ru) Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
BR0214806A (pt) Composições farmacêuticos de 5,7,14-triazatetraciclo-{10.3.1.02,11.0,4,9]-hexadeca-2(1 1),3,5,7,9-penteno
DE60202477D1 (de) Vorrichtung zur verabreichung einer substanz
ID30353A (id) Obat semprot topikal
NO950051L (no) Plaster for lavtsmeltende og/eller flyktige aktive bestanddeler
DE69730988D1 (de) Neue formulierungen zur transdermale verabreichung von fluoxetinacetat und fluoxetinmaleat
WO2000037422A3 (en) Ion channel modulating agents
DE60002885D1 (de) Wässrige formulierung zur nasalen verabreichung
AU2284001A (en) Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
EP1344526A4 (en) PREVENTIVE / REMEDY AGENTS FOR INFLAMMATORY DISEASES OF THE AIRWAY
ITRM920900A1 (it) Formulazione proteica coadiuvante nella prevenzione e cura delle parodontiti e di altre patologie batteriche del cavo orale.
WO2004024187A3 (en) Compositions to reduce congestion and methods for application thereof to the nasal membrane
ES2184880T3 (es) Asociacion hormonal estrogeno-progestageno, su procedimiento de preparacion y su utilizacion en medicamentos.
MX2007004861A (es) Derivados de sulfonamida novedosos como moduladores de receptor glucocorticoide para el tratamiento de enfermedades inflamatorias.
BR0210327A (pt) Microcápsulas para proteção do hálito
AU1549700A (en) Ion channel modulating agents
DE59914183D1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
ATE296814T1 (de) Ionenkanal modulierende mittel
PT1198224E (pt) Formulacoes de solucoes de esteroides para administracao por inalacao
GB9827034D0 (en) Delivery formulation
DK0742716T3 (da) Farmaceutisk sammensætning til systemisk transdermal indgivelse med det aktive middel morphin-6-glucuronid